Combination immunotherapy mitigated metastatic melanoma in early trial

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2015年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1299 / 1299
页数：1
相关论文
共 50 条
  • [41] Combination of targeted therapy and immunotherapy in melanoma
    Christian U. Blank
    Anna I. Hooijkaas
    John B. Haanen
    Ton N. Schumacher
    Cancer Immunology, Immunotherapy, 2011, 60 : 1359 - 1371
  • [42] A New Combination Immunotherapy in Advanced Melanoma
    Frampton, Adam E.
    Sivakumar, Shivan
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (01): : 91 - 92
  • [43] Rational combination of cancer immunotherapy in melanoma
    Mandala, Mario
    Rutkowski, Piotr
    VIRCHOWS ARCHIV, 2019, 474 (04) : 433 - 447
  • [44] Combination immunotherapy in management of advanced melanoma
    Kapoor, Akhil
    Rungta, Ankita
    Kumar, Harvindra Singh
    Kumar, Rajesh
    CLINICAL CANCER INVESTIGATION JOURNAL, 2014, 3 (04): : 361 - 362
  • [45] MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA
    ATKINS, MB
    OBOYLE, KR
    SOSMAN, JA
    WEISS, GR
    MARGOLIN, KA
    ERNEST, ML
    KAPPLER, K
    MIER, JW
    SPARANO, JA
    FISHER, RI
    ECKARDT, JR
    PEREIRA, C
    ARONSON, FR
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) : 1553 - 1560
  • [46] A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma
    Deniger, Drew C.
    Kwong, Mei Li M.
    Pasetto, Anna
    Dudley, Mark E.
    Wunderlich, John R.
    Langhan, Michelle M.
    Lee, Chyi-Chia Richard
    Rosenberg, Steven A.
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 351 - 362
  • [47] Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon α
    Vaishampayan, U
    Abrams, J
    Darrah, D
    Jones, V
    Mitchell, MS
    CLINICAL CANCER RESEARCH, 2002, 8 (12) : 3696 - 3701
  • [48] Talimogene laherparepvec monotherapy, an elegant alternative to systemic immunotherapy for the treatment of early metastatic melanoma
    Franke, V.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (01) : 20 - 21
  • [49] Early versus late response to PD-1-based immunotherapy in metastatic melanoma
    Lodde, Georg C.
    Zhao, Fang
    Herbst, Rudolf
    Terheyden, Patrick
    Utikal, Jochen
    Pfoehler, Claudia
    Ulrich, Jens
    Kreuter, Alexander
    Mohr, Peter
    Gutzmer, Ralf
    Meier, Friedegund
    Dippel, Edgar
    Weichenthal, Michael
    Jansen, Philipp
    Kowall, Bernd
    Galetzka, Wolfgang
    Hoerst, Fabian
    Kleesiek, Jens
    Hellwig, Birte
    Rahnenfuehrer, Jorg
    Rajcsanyi, Luisa
    Peters, Triinu
    Hinney, Anke
    Placke, Jan-Malte
    Sucker, Antje
    Paschen, Annette
    Becker, Juergen C.
    Livingstone, Elisabeth
    Zimmer, Lisa
    Tasdogan, Alpaslan
    Roesch, Alexander
    Hadaschik, Eva
    Schadendorf, Dirk
    Griewank, Klaus
    Ugurel, Selma
    EUROPEAN JOURNAL OF CANCER, 2024, 210
  • [50] Immunotherapy in octogenarian and nonagenarian metastatic melanoma patients
    Cybulska-Stopa, B.
    Zietek, M.
    Czarnecka, A. M. M.
    Piejko, K.
    Galus, L.
    Ziolkowska, B. E.
    Kieszko, S.
    Kempa-Kaminska, N.
    Calik, J.
    Zemelka, T.
    Rolski, J.
    Rogala, P.
    Kubiatowski, T.
    Suwinski, R.
    Mackiewicz, J.
    Rutkowski, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S752 - S753
12345